Left to right: Joss J. De Wet, M.D., Johnson & Johnson’s Brian Woodfall, M.D., and artist Tiko Kerr Andy Meyers at M3 Creative

Meet 3 men who’ve been on the front lines of HIV treatments for decades

Johnson & Johnson’s Brian Woodfall, M.D., was working at a Vancouver clinic in the mid-1990s. That’s where he met Tiko Kerr, who became one of the first patients to take the company’s HIV medicines—and has thrived to this day. For National AIDS Awareness Month, watch as Kerr, Dr. Woodfall and fellow researcher Joss J. De Wet, M.D., reflect on how those treatments have saved lives and continue to evolve, in this moving video.

Written by Johnson & Johnson

| July 28, 2022

July 28, 2022

Left to right: Joss J. De Wet, M.D., Johnson & Johnson’s Brian Woodfall, M.D., and artist Tiko Kerr Andy Meyers at M3 Creative

Johnson & Johnson J&J Innovative Medicine

We’re committed to helping lead the fight against HIV/AIDS

Read about the many ways Johnson & Johnson is working to #makeHIVhistory.

Learn more

More from Johnson & Johnson

Health & wellness

October 29, 2025

Juvenile myasthenia gravis: Inside one adolescent’s journey

The condition is typically diagnosed in adults, but research suggests an uptick in adolescent patients. Learn more about the rare autoantibody disease, how one teen is managing it and why Johnson & Johnson is working to improve treatment options for patients of all ages.

Innovation

October 28, 2025

5 ways Johnson & Johnson is innovating in medicines and therapies

From rare diseases to all-too-common cancers, Johnson & Johnson is on a mission to improve treatment options for people around the globe. Learn more about how the company is working to create new therapies for IBD, lung cancer, major depressive disorder, bladder cancer, myasthenia gravis and more.